throbber
JOURNAL OF AEROSOL MEDICINE
`Volume 18, Number 3, 2005
`© Mary Ann Liebert, Inc.
`Pp. 311–324
`
`Comparison of Cascade Impaction and Laser Diffraction
`for Particle Size Distribution Measurements
`
`JOCHEN ZIEGLER, Ph.D., and HERBERT WACHTEL, Ph.D.
`
`ABSTRACT
`
`The Andersen cascade impactor (ACI) and laser diffraction (LD) can be correlated at ambient
`temperature for aqueous drug formulations atomized by Soft Mist™ inhalers. A comparison
`of the two particle size determination methods at different conditions (flow rate, relative hu-
`midity) was performed. Under well-defined conditions, the faster LD can substitute the time-
`consuming ACI at least for routine tests. The measurements were performed with three dif-
`ferent drug formulations. The aerosol was generated by Soft Mist™ inhalers, and the droplet
`distributions were measured simultaneously using a laser diffraction analyzer together with
`the eight-stage Andersen cascade impactor. The simultaneous measurements ensure that
`aerosol and air conditions are identical for both LD and ACI. In order to measure the scat-
`tered laser light intensity of the aerosol passing the induction port, glass windows were fit-
`ted to the induction port. The evaporation effect of the aqueous aerosols on the PSD was
`investigated at ambient humidity and high humidity (RH ⬎ 90%). The simultaneous deter-
`mination of the droplet size distribution leads to a good correlation between the ACI and LD
`method only if the measurements were performed at RH of ⬎90%. The humidity of the am-
`bient air had the strongest influence on PSD not only for ACI, but also for LD. In our set-up,
`the almost saturated air prevents aqueous droplets from drying. The influence of the flow
`rate on LD was negligible, whereas for ACI, a flow rate dependence is expected. The advan-
`tages of LD and the demonstrated compatibility to established EP/USP methods motivate the
`substitution of the ACI and the use of LD for routine measurements.
`
`Key words: soft mist inhaler, particle size distribution, impactor, laser diffraction
`
`INTRODUCTION
`
`IN THE PHARMACEUTICAL INDUSTRY, the determi-
`
`nation of particle size distributions (PSD) of at-
`omized aerosols is important for estimating the
`deposition characteristic in the lungs. In practice
`the common principle for measuring the PSD is
`the impaction method as described in the USP
`26.(1) The cascade impactor can be considered as
`
`a simplified model of the respiratory system of
`human beings. The aerosol is guided by means
`of an air stream at defined flow rate through the
`rectangular bend (model of the human throat)
`and the following impaction stages (modelling
`the particle size dependent deposition in differ-
`ent parts of the lung). Further information about
`the cascade impactor and the measurement prin-
`ciple can be found in a monograph series by
`
`Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
`
`311
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 1
`
`

`

`312
`
`Lodge and Chan.(2) This method is well accepted
`by the national medical agencies due to its sim-
`plicity and robustness. The whole system is de-
`fined and can be described by only a few para-
`meters like the flow rate of the air stream and the
`geometry of the impactor, for example, the num-
`ber of nozzles, the jet diameters defined by the
`nozzle diameters of the nozzle plates, the dis-
`tances of the nozzles to the impaction plates and
`the length of the nozzles. However, the process
`of aerosol analysis is time consuming and there-
`fore not suitable for routine measurements with
`large batch numbers. Especially the analysis of
`the different mass fractions on the impaction
`stages is very labor intensive. Hence it is neces-
`sary to establish faster alternatives for particle
`size determinations based, for example, on laser
`diffraction (LD). A typical laser diffraction in-
`strument and further details are given in the In-
`ternational Standard ISO 13320-1,(3) for example.
`A laser is used to generate a monochromatic,
`coherent, parallel beam that illuminates the dis-
`persed particles after expansion by the beam pro-
`cessing unit. In many conventional systems, the
`measuring zone has ambient air conditions. En-
`closures are offered for light protection. The ef-
`fect of ambient air interacting with the aerosol is
`often neglected. The incident light is scattered by
`the ensemble of dispersed particles. The total an-
`gular intensity distribution (I[␪]), consisting of
`both direct and scattered light, is then focused
`by a lens system onto a multi-element detector,
`where a discrete spatial intensity distribution
`(I[r]) is recorded. By means of a computer the par-
`ticle size distribution can be calculated which best
`approximates (I[r]).
`In order to introduce and establish the laser dif-
`fraction method as a tool that may replace the cas-
`cade impactor for routine measurements on phar-
`maceutical inhalers, the equivalence of both
`methods must be proven. Using continuously op-
`erating nebulizers, Clark,(4) Kwong et al.,(5) and
`Vecellio None et al.(6) established a good corre-
`spondence between the methods regarding the
`aerodynamic diameters and the geometrical stan-
`dard deviations. However, only Clark(4) simulta-
`neously measured the PSD of a non-volatile
`aerosol (dibutyl phthalate) with both methods.
`Kwong et al.(5) used aqueous aerosols which
`are affected by evaporation. By laser diffraction,
`they investigated a free aerosol cloud. On the
`other hand, the standard set-up was used for the
`
`ZIEGLER AND WACHTEL
`
`Andersen impactor measurements and uncondi-
`tioned room air was entrained into the nebulizer
`chamber. The authors stressed the importance of
`humidity control during the cascade impactor
`measurement, and achieved this goal by cooling
`the cascade impactor in order to minimize evap-
`orative losses. However, Kwong et al. did not find
`any evidence suggesting a significant evaporative
`loss of fine particles using LD.
`Vecellio None et al.(6) have used a T piece sam-
`pling technique with LD in order to have the
`same experimental set up as cascade impactors
`used in European Standard EN 13544-1. The au-
`thors have demonstrated that it is important to
`use the same experimental set up to compare the
`different measurement methods; for example,
`when sampling at a 90-degree angle at 2 L/min
`air flow in accordance with EN 13544-1,(7) it was
`shown that LD used with T piece underestimated
`the MMAD of the aerosol produced by nebuliza-
`tion with respect to sampling at 0-degree angle at
`15 L/min. The tests were performed close to stan-
`dard conditions in the range of 23 ⫾ 2°C and
`40–75% RH.
`As far as metering inhalers are concerned,
`Ziegler and Wachtel(8,9) described the first suc-
`cessful attempts to establish a correlation be-
`tween laser diffraction and cascade impaction us-
`ing aqueous aerosols generated by soft mist
`inhalers. Dedicated equipment is required as the
`soft mist inhalers generate a high particle density
`(⬎106 particles/cm3 ) for a time span of ⱕ1.5 sec.
`The metered dose operation of the inhaler pre-
`vents the entrained air from establishing an equi-
`librium humidity at reduced temperature and
`motivates the need for assessment of individually
`delivered doses. A simultaneous measurement is
`the only way to assess one individual dose with
`both methods, LD and ACI, respectively. For that
`reason, the measurements were performed si-
`multaneously and evaporation was accounted for
`by a comparison between volatile aqueous liquid
`formulations and non-volatile aerosols. The
`aqueous aerosols were generated by a soft mist
`inhaler. Humidified air with RH of ⬎90% was
`passed through inhaler, induction port and ACI.
`The measurements were performed at ambient
`temperature (22 ⫾ 2°C). For the simultaneous
`measurement of the PSD with LD and ACI the
`induction port (also denoted USP-throat, see USP
`26(1)) was modified without changing the char-
`acteristic impactor geometry.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 2
`
`

`

`COMPARISON OF CASCADE IMPACTION AND LASER DIFFRACTION
`
`313
`
`MATERIALS AND METHODS
`
`Prototype Respimat® soft mist inhalers were
`used to generate the aqueous aerosols. The in-
`haler uses the mechanical energy of a loaded
`spring which drives a piston. A metered amount
`of liquid is pressed through a micro-nozzle, pro-
`ducing an aerosol of the desired MMD, for ex-
`ample, MMD of ⬍5 ␮m. The investigated for-
`mulations were close to final formulations
`intended for market and contained different ac-
`tive drugs (active drug concentration c indicated)
`as well as excipients. They are called formulation
`A (c ⫽ 0.049%), B (c ⫽ 0.198%), and C (c ⫽
`0.833%). By this choice, the concentration c of
`drugs ranged from c ⫽ 0.049%, 0.198% to 0.833%.
`The density of the aqueous formulations was
`close to unity (1.0 g/cm3). A single actuation of
`the inhaler resulted in a spray duration of 1.5 sec.
`The non-volatile aerosol was generated with a
`Sinclair-LaMer type aerosol generator MAG-2010
`(PALAS® GmbH in D-76229 Karlsruhe, Ger-
`many). This aerosol was used for testing the reli-
`ability of the laser diffraction analyser. The gen-
`erator is capable to generate adjustable particle
`diameters between approximately 0.3 and 6 ␮m
`with a geometric standard deviation ␴g less than
`1.15 and a number concentration up to 106 cm⫺3.
`In the boiler where the aerosol material is vapor-
`ized, the temperature controls the particle diam-
`eter. The corresponding aerosol material is DEHS
`(Di-2-Ethylhexyl-Sebacate).
`
`Particle size measurement
`Aerosol droplet distributions were measured
`using the Sympatec HELOS laser diffraction
`analyser (Sympatec GmbH, D-38678 Clausthal-
`Zellerfeld, Germany) at ␭ ⫽ 632.8 nm (He-Ne
`laser) together with an Andersen Mark II 8-stage
`cascade impactor operated at 28.3 L/min with the
`corresponding cut-off points 0.4, 0.7, 1.1, 2.1, 3.3,
`4.7, 5.8, and 9.0 ␮m. To our knowledge, the cut-
`off diameter of the throat is not well defined in
`the range from 10 to 20 ␮m. We assumed 10 ␮m
`as a first approximation. As another experimen-
`tal restriction, particles with diameters below 1
`␮m are hardly detectable with the LD configura-
`tion used for the presented measurements. There-
`fore the comparison of the two methods is lim-
`ited to one decade of particle sizes from 1 to
`10 ␮m.
`
`The analysis of the drug was performed in the
`case of formulation C with an UV/VIS scanning
`spectrophotometer at the wavelength ␭ ⫽ 218 nm
`and sometimes additionally at the wavelength
`␭ ⫽ 276 nm. The detection of the other two for-
`mulations A and B was performed with stan-
`dardised HPLC because of their lower drug
`concentrations. The amount of DEHS was deter-
`mined by weight.
`
`Particle size calibration
`For the control of the reliability of the gener-
`ated data the laser diffraction apparatus was
`tested with a reference reticle. The reference ret-
`icle consists of silicon particles of defined sizes
`deposited onto a glass slide. The size distribution
`of the reticle was measured with the laser dif-
`fraction apparatus used for the measurements
`and with a laser diffraction apparatus of the same
`type as a reference. The results were compared
`with the nominal values given for the reference
`reticle. The laser diffraction analyser including
`the throat (configuration with windows before
`the bend; Fig. 1) was additionally tested with a
`monodisperse aerosol. The generation process of
`the test aerosol is based on the Sinclair-LaMer
`principle by condensation of the vaporized
`aerosol material at nuclei. The aerosol consisted
`
`FIG. 1. Front side view of the experimental set-up for
`simultaneous particle size distribution measurements
`with the cascade impactor and the laser diffraction
`method. The distance from the centre of the measurement
`cone to the lens is 4 cm. The cascade impactor is used in
`a turned position for technical reasons.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 3
`
`

`

`314
`
`of DEHS (di-2-ethylhexyl-sebacate). Three differ-
`ent monodisperse particle size distributions with
`D50 values between 2 and 6 ␮m were generated
`and measured simultaneously with the laser dif-
`fraction analyser and the cascade impactor.
`
`Dedicated set-up
`We decided to stay as close as possible to the
`induction port described by the USP 26(1) and
`other pharmacopeia. Therefore, the sample in-
`duction port was used and adapted to the re-
`quirements of the LD method. In addition to mea-
`surements under ambient humidity (relative
`humidity RH ⬇ 30–45%) the particle size distri-
`bution was investigated under water vapor satu-
`rated air (RH ⬎ 90%) conditions to study the
`evaporation effect of the aqueous aerosols. The
`air inlet vents of the inhaler or the complete in-
`haler device were housed and flooded with wa-
`ter vapor saturated air which was produced by a
`humidifier operating ⬃2°C above room temper-
`ature. Excess humidified air escaped to the sur-
`rounding. The schematic experimental set-up is
`shown in Figure 1.
`In order to measure the scattered laser light in-
`tensity of the aerosol passing the induction port,
`two holes were drilled perpendicular to the air
`duct which were sealed with O-rings and glass
`windows. A three-dimensional view of the mod-
`ified USP throat is presented in Figure 2. Unless
`stated otherwise, the laser beam crossed the
`
`FIG. 2. Visualisation of the modified USP throat. In the
`direction of air flow: (a) Windows before the bend. (b)
`Windows after the bend. The inlet orifice for the laser
`beam is not visible.
`
`ZIEGLER AND WACHTEL
`
`aerosol exiting the inhaler before the bend of the
`USP throat (Fig. 2A), because the optional posi-
`tion “after the bend” (Fig. 2B) is expected to have
`a limited measurement range.
`This bend represents a first impaction stage for
`large particles, and therefore these particles can
`be detected neither by the laser diffraction nor by
`the cascade impactor. From the point of view of
`quality control of a spraying device, the windows
`positioned before the bend are preferred, because
`in this position all droplets can be detected by the
`laser system. Irrespectively of the window posi-
`tion it is possible with this set-up to measure the
`PSD with the cascade impactor and the laser dif-
`fraction method simultaneously. To ensure suffi-
`cient drug deposition on all the impactor plates
`to allow for UV spectrophotometric or HPLC
`analysis, four to eight actuations per measure-
`ment were collected. However, for the laser dif-
`fraction device one single shot would be suffi-
`cient. The laser diffraction data was analysed
`based on the Mie-theory which is applicable for
`transparent spheres. For that purpose the refrac-
`tion and absorption index of the droplets must be
`known. The refraction index of the aqueous
`aerosol particles was 1.33 and the absorption was
`0.0. For the DEHS particles, the refraction index
`was 1.45 and the absorption was 0.0. It is impor-
`tant to use the Mie correction to take into account
`the increased scattering of light from smaller
`droplets compared to the Fraunhofer theory.(11,12)
`
`Data and statistical analysis
`The PSD measured with laser diffraction was
`calculated automatically from the scattered light
`intensities striking the 31 detector elements. The
`Sympatec HELOS software used for the calcula-
`tion was WINDOX version 3.3.
`The basis for the calculation of the PSD mea-
`sured with the cascade impactor was the total
`mass detected with the photometer or HPLC; that
`is, the total mass is the sum of all masses recov-
`ered on the different impaction stages and in the
`USP throat for all measurements with LD before
`the bend (Fig. 2A). In the alternative position “af-
`ter the bend” (Fig. 2B) the mass deposited in the
`USP throat was excluded. The implicit assump-
`tions for the comparison of aerodynamic diame-
`ter (dae) measured by ACI and geometric diame-
`ter (dg) measured by LD are a constant density of
`the particles, for example, ␳p ⫽ 1 g/cm3 for the
`present aqueous formulations, and constant ho-
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 4
`
`

`

`COMPARISON OF CASCADE IMPACTION AND LASER DIFFRACTION
`
`315
`
`mogeneous concentration of drug among all
`droplets, the latter being required for the ACI
`analysis. In the Stokes regime, theory predicts
`dae ⫽ (␳p/␳ref)*dg, with ␳ref ⫽ 1 g/cm3. Therefore,
`in the present case of aqueous formulations, the
`diameters should be equal.
`All PSD data were converted in percentage of
`the cumulative undersize fraction CF with relation
`to the cut-off diameters of the cascade impactor,
`for example, CF(5.8 ␮m) means the fraction in per-
`centage of a particle ensemble with diameters less
`or equal than 5.8 ␮m. The PSD and the character-
`istic aerosol parameters D50, ␴g, and fine particle
`fraction (FPF) (⬍5.8 ␮m) measured with the two
`particle size detection methods were evaluated
`qualitatively (visual assessment) and if appropri-
`ate quantitatively by means of a significance analy-
`sis (t-test, confidence intervals(13)). The correlations
`between the different measurements were charac-
`terized by linear regressions between the cumu-
`lated fractions of the respective size distributions.
`The geometric standard deviation ␴g is given
`by the following:
`冱ni(ln di ⫺ ln dg)2
`ᎏᎏᎏ
`N ⫺ 1
`
`␴g ⫽冤
`
`冥1/2
`
`dg ⫽ (d1 . . . dN)1/N (1)
`
`RESULTS
`
`Reliability tests
`The results of the reticle measurements are
`shown in Table 1. In order to obtain representa-
`tive results, seven measurements per laser dif-
`fraction analyser at different reticle positions
`were performed. The results of the test analyser,
`which was used for all subsequent investigations,
`show excellent correspondence to the reference
`analyser results (t-test, n ⫽ 7, p ⬎ 0.05). However,
`all nominal values are slightly but significantly
`(NE, t-test, n ⫽ 7, p ⬍ 0.05) higher than the mea-
`sured ones.
`Since the reticle spot diameters are quite large
`it is reasonable to control the reliability of the
`laser analyser in a size range less than 10 ␮m. No
`reticle was available in this size interval. There-
`fore an aerosol generator was used. The charac-
`teristic parameters of the monodisperse PSD gen-
`erated by the MAG-2010 aerosol generator are
`presented in Table 2. Three different boiler tem-
`peratures and hence three PSD were investigated
`simultaneously with the laser diffraction appara-
`tus and the cascade impactor. The cascade im-
`pactor served as the reference test method.
`The D50 values show differences from 0.4 to 0.6
`␮m between the two detection methods (t-test,
`n ⫽ 8, p ⬎ 0.05). Differences of this order of mag-
`nitude are expected due to slightly different cal-
`ibrations and the completely different operating
`principles of LD and ACI. All geometric standard
`deviations (t-test, n ⫽ 8, p ⬎ 0.05) are statistically
`equal.
`
`INFLUENCE OF THE THROAT
`MODIFICATION ON THE PSD
`
`The original induction port was modified and
`the usual position of the impactor was changed
`during the simultaneous measurements with
`
`where ni number of particles with diameter di;
`N ⫽ total number of particles; and dg geometric
`particle diameter.
`Under the prerequisite of a log-normal distri-
`bution (the logarithm of the particle diameters is
`normal distributed) the geometric standard devi-
`ation is equal to the following:
`D84ᎏ
`D50ᎏ
`D84ᎏ
`D16
`D16
`D50
`Eq. 2 is used in the following for calculating ␴g.
`D50 is the median diameter, D16 and D84 are the
`diameters at which the cumulative size distribu-
`tion reaches 16% and 84%, respectively.
`
`␴g ⫽
`
`⫽
`
`⫽冤
`
`冥1/2
`
`(2)
`
`TABLE 1. PSD OF A RETICLE MEASURED WITH TWO LASER DIFFRACTION ANALYSERS
`OF THE SAME TYPE (TEST ANALYZER AND REFERENCE ANALYZER)
`
`Test analyzer (n ⫽ 7)
`
`Reference analyzer (n ⫽ 7)
`
`Nominal value
`
`D10 [␮m] ⫾ SD
`D50 [␮m] ⫾ SD
`D90 [␮m] ⫾ SD
`
`27.49 ⫾ 0.84
`36.85 ⫾ 1.58
`47.03 ⫾ 2.12
`
`27.61 ⫾ 0.47
`36.91 ⫾ 1.16
`47.54 ⫾ 2.48
`
`30.61
`39.05
`49.69
`
`The mean values of D10, D50, and D90 are compared with the nominal value. Measurements according to reticle
`manufacturer’s instructions without throat.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 5
`
`

`

`316
`
`T ⫽ 180°C
`
`T ⫽ 210°C
`
`T ⫽ 240°C
`
`ZIEGLER AND WACHTEL
`
`TABLE 2. PSD OF A MONODISPERSE TEST AEROSOL OF DEHS
`
`D50 ⫾ SD [␮m]
`␴g ⫾ SD
`D50 ⫾ SD [␮m]
`␴g ⫾ SD
`D50 ⫾ SD [␮m]
`␴g ⫾ SD
`
`LD (n ⱖ 8)
`
`1.92 ⫾ 0.10
`1.17 ⫾ 0.32
`3.33 ⫾ 0.18
`1.16 ⫾ 0.08
`6.03 ⫾ 0.30
`1.19 ⫾ 0.07
`
`ACI (n ⱖ 8)
`
`2.29 ⫾ 0.38
`1.32 ⫾ 0.32
`3.90 ⫾ 0.06
`1.12 ⫾ 0.03
`5.60 ⫾ 0.17
`1.15 ⫾ 0.25
`
`Difference
`
`⫺0.37
`⫺0.15
`⫺0.57
`⫺0.04
`⫺0.43
`⫺0.04
`
`The particle size was tuned by the temperature T inside the Sinclair LaMer generator. For each temperature, at least
`eight measurements were performed. LD measurements before the bend (cf. Fig. 2a).
`
`laser diffraction and cascade impactor. These
`modifications do not distort the PSD, as shown
`in Figure 3. The linear correlation of the cu-
`fractions yields CF(modif) ⫽ 0.87 ⫹
`mulated
`0.98*CF(original) with R ⫽ 0.999 for n ⫽ 9 stages,
`including filter. The cumulative fraction curves
`overlap and justify the use of the modified throat
`for the correlation studies. For the experiment
`the formulation C with the highest concentration
`(c ⫽ 0.833%) was used and all measurements
`were performed under saturated air conditions
`(RH ⬎ 90%).
`
`INFLUENCE OF THE RELATIVE
`HUMIDITY ON THE PSD
`
`It is known that the humidity of the air affects
`the PSD of aqueous aerosols measured with the
`
`cascade impactor.(5) Due to evaporation, the size
`distribution is shifted to smaller particles if RH is
`reduced. Even if the laser diffraction method was
`used, where evaporation should not play such a
`dominant role as for the cascade impactor be-
`cause of shorter times of flight, the PSD depends
`also on the relative humidity of the ambient air.
`LD measurements at 28 L/min and two humid-
`ity levels are presented in Figure 4. For compar-
`ison, a measurement without air flow at an ini-
`tial RH of 30–45% has been added. However, it
`is not recommended to use the modified throat
`without air flow, because the aerosol fills the
`whole throat and deposits on the windows. The
`data relate to laser diffraction measurements on
`formulation C with the highest drug concentra-
`tion (c ⫽ 0.833%). The flow rate was 28.3 L/min.
`The linear correlation of the cumulated fractions
`yields CF(RH 30–40%) ⫽ ⫺3.07 ⫹ 0.92*CF(RH ⬎
`
`FIG. 3. Cumulative undersize fraction in dependence of the cut-off diameters for ACI (standard set up) and with
`modified throat (windows before the bend). The full lines are sigmoidal fits. Formulation C (c ⫽ 0.833%) was used.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 6
`
`

`

`COMPARISON OF CASCADE IMPACTION AND LASER DIFFRACTION
`
`317
`
`FIG. 4. The RH of the air influences the laser diffraction results. The detected FPF(⬍5.8 ␮m) value increases and the
`D50 decreases with increasing humidity. For comparison, a measurement without air flow was included (dotted line).
`Formulation C (c ⫽ 0.833%) was used.
`
`90%) with R ⫽ 0.987 for n ⫽ 9 stages, including
`filter.
`
`FLOW RATE DEPENDENCE ON THE PSD
`
`The PSD was investigated by laser diffraction for
`different flow rates and under saturated air condi-
`tions (Fig. 5). The flow rate was varied between 18
`
`and 38 L/min. No systematic dependence was es-
`tablished between the flow rate and the D50 values
`or FPF respectively. The measurements were per-
`formed with the formulation C with concentration
`c ⫽ 0.833% under saturated air conditions. As
`shown in Figure 5, the D50 value varied between
`4.32 and 4.64 ␮m, which is well within an error
`band of ⫾0.2 ␮m which must be taken into account
`when performing LD measurements.
`
`FIG. 5. Cumulative Fraction (CF) versus particle diameter measured by LD. The flow rate was varied between 18
`and 38 L/min. Formulation C (c ⫽ 0.833%) under saturated air conditions (RH ⬎ 90%).
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 7
`
`

`

`318
`
`ZIEGLER AND WACHTEL
`
`TABLE 3. INFLUENCE OF THE MEDIAN PARTICLE SIZE ON THE DOSE TRANSMITTED BY
`THE USP SAMPLE INDUCTION PORT (NOT MODIFIED, ACCORDING TO USP(1))
`
`Device
`
`MMD ⫾ SD
`(␮m)
`
`GSD ⫾ SD
`(⫺)
`
`Delivered dose ⫾ SD
`(␮g)
`
`Residue in throat ⫾ SD
`(␮g)
`
`Dose after bend ⫾ SD
`(␮g)
`
`1
`2
`3
`4
`
`4.3 ⫾ 0.1
`4.7 ⫾ 0.1
`8.4 ⫾ 0.4
`11.6 ⫾ 0.3
`
`1.7 ⫾ 0.02
`1.7 ⫾ 0.02
`1.8 ⫾ 0.00
`1.7 ⫾ 0.03
`
`4.7 ⫾ 0.3
`5.4 ⫾ 0.3
`5.5 ⫾ 0.4
`5.8 ⫾ 0.2
`
`0.3 ⫾ 0.0
`0.9 ⫾ 0.2
`1.5 ⫾ 0.2
`3.9 ⫾ 0.02
`
`4.2 ⫾ 0.2
`4.3 ⫾ 0.1
`3.7 ⫾ 0.1
`2.1 ⫾ 0.03
`
`The results are based on three measurements each. Experimental inhalers with modified nozzles. Size data refer to
`values before the bend (cf. Fig. 2a). Air Flow ⫽ 28.3 L/min. Formulation A (c ⫽ 0.049%) was used at RH ⬎ 90%.
`
`EFFECT OF THE INDUCTION PORT
`
`In order to investigate the influence of the bend
`of the induction port, two induction ports were
`used. One port had the windows in front of the
`bend (Fig. 2A), and another port had the win-
`dows behind the bend (Fig. 2B). As long as
`aerosols with MMD of ⬍5 ␮m are investigated,
`there is only a minor influence of the impaction
`process at the bend in the induction port. How-
`ever, larger particles become impacted and the
`correspondence between LD in the preferred con-
`figuration (windows in front of the bend; Fig. 2A)
`and the CI will not hold, because the LD set-up
`is able to detect these large particles, which are
`not sizable by the CI. Table 3 gives an impression
`of the amount of drug retained in the USP throat
`as a function of the particle size MMD for a typ-
`ical aerosol with GSD of ⬃1.7. An air flow of 28.3
`L/min was applied.
`Table 4 gives the direct comparison between
`ACI and LD in the two different configurations.
`Depending on the position of the LD window, the
`effect of the throat is measured or not. This is
`taken into account for the impactor calculations,
`
`too, by considering (Fig. 2A) or excluding (Fig.
`2B) the dose deposited in the throat. Conse-
`quently, CF(CI) reached 100% at the throat cut-
`off size. In case of the window before the bend
`the linear correlation of the cumulated fractions
`yields CF(CI, before) ⫽ 4.2⫹0.939*CF(LD, before)
`with R ⫽ 0.998 for n ⫽ 9 stages, including filter.
`The configuration window after the bend yields
`CF(CI, after) ⫽ 1.8 ⫹ 0.998*CF(LD, after) with
`R ⫽ 0.997 for n ⫽ 9 stages, including filter. The
`correlation of data is presented in Figure 6.
`
`CORRELATION BETWEEN ACI AND LD
`
`The motivation for the present comparison
`between ACI and LD is illustrated by Figure 7.
`It shows the particle size distributions for for-
`mulation C, measured separately with the cas-
`cade impactor at RH of ⬎90% and the laser dif-
`fraction method under ambient conditions. The
`cumulative fractions differ significantly from
`each other for diameters less than 9 ␮m. The lin-
`ear correlation of the cumulated fractions yields
`CF(CI, RH 90%) ⫽ ⫺8.12 ⫹ 0.999*CF(LD, RH
`
`TABLE 4. D50, ␴G, AND FPF (⬍5.8 ␮M) FOR THE DIFFERENT CONFIGURATIONS
`
`LD BEFORE AND AFTER THE BEND (CF. FIG. 2)
`
`Formulation C
`(c ⫽ 0.833%)
`LD before bend
`
`Formulation C
`(c ⫽ 0.833%)
`LD after bend
`
`D50 ⫾ SD [␮m]
`␴g ⫾ SD
`FPF ⫾ SD [%]
`
`ACI (n ⫽ 13)
`
`4.43 ⫾ 0.19
`1.86 ⫾ 0.14
`68.5 ⫾ 2.3
`
`LD (n ⫽ 12)
`
`4.59 ⫾ 0.17
`1.76 ⫾ 0.04
`66.2 ⫾ 2.7
`
`ACI (n ⫽ 6)
`
`4.17 ⫾ 0.26
`1.61 ⫾ 0.04
`77.2 ⫾ 2.5
`
`LD (n ⫽ 6)
`
`4.12 ⫾ 0.15
`1.73 ⫾ 0.04
`74.2 ⫾ 1.9
`
`Formulation C (c ⫽ 0.833%) was used. Data of configuration “LD before the bend” (Fig. 2a) are taken from Table
`5. For the CI results in the configuration “LD after the bend” (Fig. 2b), the dose deposited in the throat was excluded
`from the calculation. RH ⬎ 90%.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 8
`
`

`

`COMPARISON OF CASCADE IMPACTION AND LASER DIFFRACTION
`
`319
`
`FIG. 6. Correlation of Cumulative Fraction (CF) measured with the ACI as function of the Cumulative Fraction (CF)
`measured with LD. Two cases are compared: Window before the bend and window after the bend. Test substance is
`formulation C (c ⫽ 0.833%) under saturated air conditions (RH ⬎ 90%).
`
`ambient) with R ⫽ 0.987 for n ⫽ 9 stages in-
`cluding filter.
`The comparison is restricted to the range from
`1 ␮m (detection limit of LD in the present set-up
`is between 0.5 and 1 ␮m) up to 9 ␮m, which is
`the highest cut-off diameter of the cascade im-
`pactor at 28.3 L/min. Including the throat, the
`comparison may be extended to approximately
`10 ␮m.
`The most obvious way to investigate the cor-
`relation of two PSD analysers is the simultaneous
`
`measurement of the particle size distribution with
`both methods. The correlation studies were per-
`formed at RH of ⬎90% (measurement of RH be-
`hind the impactor) and at a flow rate of 28.3
`L/min for all drug formulations. The modified
`induction port having the inlet and outlet win-
`dows for the laser beam in front of the bend (Fig.
`2A) was used. The experimental set-up is de-
`picted in Figure 1. In Figure 8, the histograms il-
`lustrate the PSD correlation between the LD and
`ACI method.
`
`FIG. 7. Comparison of the Cumulative Fraction (CF) for different measurement conditions (ACI versus LD and
`RH ⬎ 90% versus RH ⬇ 30–45%). The distributions were not measured simultaneously. Formulation C (c ⫽ 0.833%)
`was used.
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 9
`
`

`

`320
`
`ZIEGLER AND WACHTEL
`
`FIG. 8. Cumulative Fraction (CF) versus the cut-off diameters of the ACI for the formulation A (c ⫽ 0.049%), for-
`mulation B (c ⫽ 0.198%), and formulation C (c ⫽ 0.833%). Simultaneous measurements under saturated air conditions
`(RH ⬎ 90%).
`
`Figure 9 shows an excellent correspondence be-
`tween the LD and the ACI results. The linear cor-
`relation of the cumulated fractions yields for for-
`mulation A: CF(ACI) ⫽ 0.56 ⫹ 1.03*CF(LD) with
`R ⫽ 0.997, for formulation B: CF(ACI) ⫽ ⫺0.5 ⫹
`
`0.97*CF(LD) with R ⫽ 0.997, and for formulation
`C: CF(ACI) ⫽ 4.68 ⫹ 0.95*CF(LD) with R ⫽ 0.998.
`All values refer to n ⫽ 9 stages including filter.
`Formulation C shows the strongest deviation
`from the ideal regression line which would read
`
`Downloaded by Society - Active - International Society for Aerosols in Medicine (ISAM) from www.liebertpub.com at 11/09/20. For personal use only.
`
`Liquidia's Exhibit 1058
`Page 10
`
`

`

`COMPARISON OF CASCADE IMPACTION AND LASER DIFFRACTION
`
`321
`
`FIG. 9. Cumulative fraction (CF) measured with the ACI in dependence of the cumulative fraction (CF) measured
`with LD. The experimental data represent the respective cut-off points of the ACI (i.e., the CF values for the 0.4, 0.7,
`1.1, 2.1, 3.3, 4.7, 5.8, 9.0 ␮m cut-off sizes). The largest value corresponds to the throat value. Each formulation is close
`to the ideal case (straight line) where CFACI and CFLD should be equal.
`
`CF(ACI) ⫽ 0 ⫹ 1.0*CF(LD) with R ⫽ 1. The mea-
`surable content of fine particles with diameter be-
`low 1 ␮m gives raise to this deviation, as our LD
`apparatus does not detect these fines.
`Table 5 summarizes the corresponding charac-
`teristic aerosol parameters D50, ␴g, and FPF(⬍5.8
`␮m). The D50 values determined by ACI and LD,
`respectively, coincide within intervals of the cor-
`responding standard deviations. The overall vari-
`ability as documented by the standard deviations
`is comparable for LD and ACI. The high numbers
`of independent experiments (12 ⬍ n ⬍ 18) result
`in t-tests indicating a statistically significant dif-
`ference below a difference of the mean D50 of ACI
`and LD of 0.2 ␮m. In our experiments, this is the
`case for formulation B, where the absolute dif-
`ference between the mean D50 values is 0.18 ␮m.
`In Table 6, the different cut-off points of the
`ACI are summarized in three size intervals [0 ␮m;
`
`1.1 ␮m], [1.1 ␮m; 4.7 ␮m] and [4.7 ␮m; ⬃10 ␮m].
`The corresponding cumulated fractions CF are
`compared for the ACI and LD method. Except for
`the [0 ␮m; 1.1 ␮m] interval good equivalence be-
`tween the ACI and LD method can be found. The
`higher CF values of the ACI evaluation in com-
`parison to the LD for the [0 ␮m; 1.1 ␮m] interval
`are caused by the detection limit of the LD. As
`shown in Figure 8, the quality of the correspon-
`dence between LD and ACI can be asses

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket